![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, April 21, 2016 7:03:46 AM
I think the biggest difficulty with Surgibot was that it was misrepresented to the investment public as robotic, and unsophisticated (medically and technically) investors bought into that. A more streamlined and honestly-represented version of it could have allowed it a place in providing enhancements to manual endoscopic surgery in select surgical situations.
TITXF management should be getting a lesson in that law firms will start sniffing around the surgical robotics sector with new interest in uncovering any potential lawsuits. I think this will actually stifle (as if that is needed) PR from Titan, although it might improve their transparency when it comes to IR.
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM